PED (MEDEASE SKIN) : Specific natural preventive treatment for Eczema and Dermatitis.


PED is a filmogenic liquid bandage designed specifically for the treatment of atopic dermatitis conditions such as eczema  and dermatitis. Presented in a 50ml tube, this product targets pro-inflammatory proteins, contaminants, and impurities. It provides a protective barrier effect, osmotic and cleaning effect, and promotes cellular repair and growth. Clinical trials have shown significant reductions in symptoms and improvements in the quality of life over a period of 6 weeks.

PED: A Revolutionary Treatment for Atopic Dermatitis



PED is a liquid filmogen bandage designed for the treatment of atopic dermatitis such as eczema or dermatitis. It comes in a 50 ml tube and targets pro-inflammatory proteins, contaminants, and impurities.


How PED Works

The product works through three primary actions:


Protective Barrier Effect

PED forms a protective layer on the skin, shielding it from external irritants and allergens that can exacerbate skin conditions like psoriasis, eczema, and dermatitis.


Osmotic and Cleaning Effect

The product helps cleanse the skin of impurities and contaminants, reducing inflammation and promoting healing.


Cellular Repair and Growth Effect

PED promotes the repair and growth of skin cells, helping to restore the skin’s natural barrier function and improve its overall health and appearance.



Clinical Trial Results

Clinical trials have shown significant improvements in patients using PED. Over a period of 6 weeks, patients experienced a reduction in symptoms such as erythema (76%), edema (74%), oozing (67%), dryness (78%), crusts (64%), and itching (67%). Additionally, the quality of life improved by 60% over 6 weeks. The global mean score related to Eczema and Dermatitis also reduced by 64%, 54.80%, and 65% respectively over 6 weeks.


Implications of the Results

These results suggest that PED could be a promising treatment option for individuals suffering from atopic dermatitis such as eczema, or dermatitis. It provides a multi-faceted approach to skin care, offering protective, cleansing, and healing benefits.



Understanding the Pathologies Treated by PED


Here is a general presentation of the pathologies that the PED product aims to treat:

Eczema: A Persistent Skin Condition


What is Eczema?

Also known as atopic dermatitis, eczema is a condition that makes the skin red and itchy. It’s common in children but can occur at any age.


Characteristics of Eczema

Eczema is long-lasting (chronic) and tends to flare periodically. It may be accompanied by asthma or hay fever.



Dermatitis: A General Skin Irritation


What is Dermatitis?

Dermatitis is a general term that describes a skin irritation. Dermatitis is a common condition that has many causes and occurs in many forms.


Characteristics of Dermatitis

It usually involves itchy, dry skin or a rash on swollen, reddened skin. Dermatitis can have many causes, from fungal infection to fleas, but it always involves an inflammatory response in the skin.



The Impact of Skin Conditions

These conditions are not just skin-deep. They can cause significant discomfort and distress, impacting the quality of life.


How PED Can Help

The PED product aims to provide relief from these conditions, reducing inflammation and promoting skin repair and growth.


  • Significative reduction in symptoms of atopic dermatitis.
  • Reduction in dryness, erythema, oedema, oozing, crust and itching
  • Improvement of the quality of life
  • Act on psoriasis, eczema and dermatitis with significative results within 6 weeks
  • Protects, hydrates and cleanses the skin.
  • Improve cellular regeration

PED Randomized, double-blind clinical trial


General informations



Journal : Clincal trial | 2013

Patients: N=107 | Test product = 56 ; Comparator =51 

Duration : 6 weeks

Inclusion : patients having single or multiple localized skin lesions for at least the last 6 weeks, which were diagnosed for dermatitis atopic either psoriasis, eczema, or dermatitis by the dermatologist during the 1st visit.

Link : Annex 4.15.3 – Shrivastava and al PED Trial


Main results


• 52 % reduction in erythema over 2 weeks, 76% over 6 weeks
• 54 % reduction in edema over 2 weeks, 74% over 6 weeks
• 48 % reduction in oozing over 2 weeks, 67% over 6 weeks
• 52 % reduction in dryness over 2 weeks, 78% over 6 weeks
• 52 % reduction in dryness over 2 weeks, 78% over 6 weeks
• 32 % reduction of the crusts over 2 weeks, 64% over 6 weeks
• 50 % reduction in itching over 2 weeks, 67% over 6 weeks
• Improvement of the quality of life by 24% over 2 weeks, 60% over 6 weeks.
• 64 % reduction in global mean score related to Psoriasis over 6 weeks.
• 54,80 % reduction in global mean score related to Eczema over 6 weeks.
• 65 % reduction in global mean score related to Dermatitis over 6 weeks.

IndicationFilmogen liquide bandage for the treatment of atopic dermatitis such as psoriasis, eczema or dermatitis.
CompositionFilmogenic glycerol, xanthan gum, honey, water, association of Vaccinium macrocarpon, Camellia sinensis and Vitris vinifera.
PresentationTube 50ml
ClassMDD Class IIa | MDR Class IIa
DirectionApply in wounds, 2-3 times a day.
PrecautionsThe product is intended for topical use only (damage skin surface) and should not be swallowed. Keep out of reach and sight of children.
Age 18+
Storage conditionsBelow 25°C
Legal manufacturer VITROBIO (France)
Product codePE